A critical discovery in cancer study is emerging with the use of nanobodies to re-engage mutated p53. This crucial cancer protector protein is frequently inactivated in various kinds of cancer, resulting uncontrolled https://bookmark-rss.com/story21775354/vhh-fragments-reactivate-the-p53-protein-new-promising-hope-for-tumor-management